Table 1.
CGS group [N = 377] | Control group [N = 380] | p value | |
---|---|---|---|
Men, no.(%) | 191 (50.7) | 202 (53.2) | 0.49 |
Age, years, mean (SD) | 81.9 ± 8.6 | 82.1 ± 8.1 | 0.77 |
Weight, Kg, mean (SD) | 58.9 ± 12.1 [N = 338] | 57.3 ± 13.1 [N = 349] | 0.09 |
Marital status, no.(%) | |||
Divorced, widow, or single | 165 (43.8) | 167 (43.2) | 0.87 |
Education, no.(%) | |||
College/University and above | 47 (12.5) | 43 (11.3) | 0.62 |
Comorbidities, no.(%) | |||
Hypertension | 260 (69.0) | 290 (76.3) | 0.02 |
Diabetes mellitus | 155 (40.8) | 123 (32.4) | 0.02 |
Stroke history | 154 (40.9) | 126 (33.2) | 0.03 |
Coronary artery disease | 86 (22.8) | 67 (17.6) | 0.08 |
Chronic obstructive pulmonary disease | 63 (16.7) | 50 (13.2) | 0.17 |
Congestive heart failure | 67 (17.7) | 71 (18.7) | 0.75 |
Atrial fibrillation | 46 (12.2) | 54 (14.2) | 0.41 |
Dementia | 89 (23.6) | 117 (30.8) | 0.03 |
Peripheral artery disease | 35 (9.3) | 26 (6.8) | 0.22 |
History of peptic ulcer | 61 (16.2) | 75 (19.7) | 0.20 |
Chronic liver disease | 36 (9.6) | 31 (8.2) | 0.45 |
Connective tissue disease | 6 (1.6) | 5 (1.3) | 0.76 |
Chronic kidney disease | 54 (14.3) | 65 (17.1) | 0.29 |
Tumor history | 53 (14.1) | 69 (18.3) | 0.12 |
Metastatic cancer | 10 (2.7) | 7 (1.8) | 0.45 |
Charlson comorbidity index ≥3 | 188 (49.9) | 192 (50.5) | 0.86 |
Barthel index score at admission ≤35 | 213 (56.5) | 202 (53.2) | 0.36 |
No. of admissiona, no.(%) | 0.06 | ||
0 | 209 (55.4) | 242 (63.7) | |
1–3 | 149 (39.5) | 125 (32.9) | |
4+ | 19 (5.0) | 13 (3.4) | |
Length of stay ≥10 days, no.(%) | 185 (48.7) | 210 (55.3) | 0.07 |
Scheduled re-admission | 6 (1.6) | 3 (0.8) | 0.50 |
30 days re-admission | 43 (11.4) | 64 (16.9) | 0.03 |
aWithin 1 year before admission date